| Literature DB >> 30728945 |
Paul Misasi1, Joseph R Keebler2.
Abstract
Lack of verification is often cited as a root cause of medication errors; however, medication errors occur in spite of conventional verification practices and it appears that human factors engineering (HFE) can inform the design of a more effective method. To this end, an HFE-driven process was designed and implemented in an urban, Midwestern emergency medical service agency. Medication error data were collected over a 54-month period, 27 months before and after implementation. A decrease in the average monthly error rate was realized for all medications administered (49.0%) during the post-intervention time period. The average monthly error rate for fentanyl, a commonly administered analgesic, demonstrated a 71.1% error rate decrease. This study is the first to evaluate the effectiveness of a team-based cross-check process for medication verification to prevent errors in the prehospital setting.Entities:
Keywords: cross-check; emergency medical services; medication errors; verification
Year: 2019 PMID: 30728945 PMCID: PMC6351968 DOI: 10.1177/2042098618821916
Source DB: PubMed Journal: Ther Adv Drug Saf ISSN: 2042-0986
Medication error types and examples.
| Error type | Example |
|---|---|
| Incorrect dose (regardless of appropriateness) | Intended 50 mg, administered 75 mg |
| Inappropriate situation for administration/ not indicated | Administration of an antiarrhythmic to a patient in cardiac arrest with pulseless electrical activity |
| No order/ not authorized (regardless of appropriateness) | Appropriate administration of drug, without protocol or online authorization |
| Wrong drug | Intended one drug, administered another |
| Dilution/ preparation error (correct dosage) | Administered a drug at full concentration when it requires dilution for clinical reasons |
| Omission of an appropriate drug | Protocol prescribes a medication that was not given |
| Inappropriate route (correct dose) | Medication given by a route that is not authorized, for example, intramuscular |
| Contraindicated | Medication is explicitly prohibited given clinical presentation, for example, known allergy |
| Expired medication | Medication is beyond the labelled expiration date |
| Incorrect time | Medications that require specific timing which lend to errors, for example, repeat doses given too soon after initial dose |
National coordinating council for medication error reporting and prevention index category definitions.[35]
| Category | Definition |
|---|---|
| Errors that do not ‘reach’ the patient/ incomplete errors | |
| No error | |
| | Circumstances or events that have the capacity to cause error (i.e. a safety concern). |
| Error, no harm | |
| | An error occurred but the error did not reach the patient, an ‘error of omission’ |
|
| |
| Error, no harm | |
| | An error occurred that reached the patient, but did not cause patient harm. |
| | An error occurred that reached the patient and required monitoring to confirm that it resulted in no harm to the patient and/or required intervention to preclude harm. |
| Error, harm | |
| | An error occurred that may have contributed to or resulted in temporary harm to the patient and required intervention. |
| | An error occurred that may have contributed to or resulted in temporary harm to the patient and required initial or prolonged hospitalization. |
| | An error occurred that may have contributed to or resulted in permanent patient harm. |
| | An error that occurred that required intervention to sustain life. |
| Error, death | |
| | An error that occurred that may have contributed to or resulted in the patient’s death. |
Figure 1.The medication administration cross-check© procedure. From The Medication Administration Cross-Check by P. Misasi, 2013, Wichita-Sedgwick County EMS System.[40] Copyright 2013 by Paul Misasi. Reprinted with permission.
Figure 2.Pop-up dialog box following the entry of a medication in the patient care report. Information of a near-miss is automatically forwarded to management.
Overall and pre/post-medication administration cross-check error analysis.
| Overall | Pre-MACC | Post-MACC | % change |
| |
|---|---|---|---|---|---|
| Month count | 54 | 27 | 27 | ||
| Responses | 250,416 | 120,503 | 129,913 | 7.8% | |
| Transports | 169,334 | 81,599 | 87,735 | 7.5% | |
| Medication doses | 73,522 | 34,531 | 38,991 | 12.9% | |
| Average monthly doses | 1361.5 | 1278.93 | 1444.11 | 12.9% | |
| Enteral medication doses | 42,609 | 20,449 | 22,160 | 8.4% | |
| Average monthly doses | 789.1 | 757.4 | 820.7 | 8.4% | |
| Parenteral medication doses | 30,913 | 14,082 | 16,831 | 19.5% | |
| Average monthly doses | 572.5 | 521.6 | 623.4 | 19.5% | |
| Fentanyl doses | 7421 | 2922 | 4499 | 54.0% | |
| Avg. monthly fentanyl doses | 137.4 | 108.2 | 166.6 | 54.0% | |
| Medication error count[ | 91 | 58 | 33 | −43.1% | |
| Average number of errors (per month) | 1.7 | 2.2 | 1.2 | −45.5% | |
| Average monthly error rate (all medications) | 0.128% | 0.169% | 0.086% | −49.0% | .013 |
| Average monthly error rate (fentanyl only) | 0.407% | 0.632% | 0.182% | −71.1% | .004 |
| Average monthly error rate (all meds excluding fentanyl) | 0.100% | 0.127% | 0.073% | −42.1% | .065 |
|
| |||||
| Error count[ | 83 | 50 | 33 | −34.0% | |
| Incorrect dose administered | 54.2% | 44.0% | 69.7% | 26.0% | |
| Average monthly errors | .83 | .81 | .85 | −4.5% | .552 |
| Inappropriate situation for administration/not indicated | 18.1% | 28.0% | 3.0% | −25.0% | |
| Average monthly errors | .28 | .52 | .04 | −92.9% | .026 |
| No order (unauthorized) | 8.4% | 10.0% | 6.1% | −3.9% | |
| Average monthly errors | .13 | .19 | .07 | −60.0% | .119 |
| Wrong drug | 7.2% | 8.0% | 6.1% | −1.9% | |
| Average monthly errors | .11 | .15 | .07 | −50.0% | .200 |
| Dilution/ preparation error (correct dose) | 6.0% | 6.0% | 6.1% | 0.1% | |
| Omission of appropriate drug | 3.61% | 4.0% | 3.0% | −1.0% | |
| Inappropriate route | 1.2% | 0.0% | 3.0% | 3.0% | |
| Contraindicated | 1.2% | 0.0% | 3.0% | 3.0% | |
| Expired medication | 0.0% | 0.0% | 0.0% | 0.0% | |
| Incorrect time of administration | 0.0% | 0.0% | 0.0% | 0.0% | |
| Error count[ | 83 | 50 | 33 | −34.0% | |
| Skill-based error | 31.3% | 24.0% | 42.4% | 18.4% | |
| Average monthly errors | .48 | .44 | .52 | 16.7% | .635 |
| Rule-based error | 44.6% | 42.0% | 48.5% | 6.5% | |
| Average monthly errors | .69 | .78 | .59 | 23.8% | .193 |
| Knowledge-based error | 24.1% | 34.0% | 9.1% | −24.9% | |
| Average monthly errors | .37 | .63 | .11 | −82.4% | .030 |
|
| |||||
| Error count[ | 83 | 50 | 33 | ||
| Category C | 88.0% | 92.0% | 81.8% | −10.2% | |
| Average monthly errors | 1.38 | 1.70 | 1.04 | −39.0 | .055 |
| Category D | 10.8% | 8.0% | 15.2% | 7.2% | |
| Average monthly errors | .17 | .15 | .19 | 25.0% | .639 |
| Category E | 1.2% | 0.0% | 3.0% | 3.0% | |
| Category F | 0.0% | 0.0% | 0.0% | 0.0% | |
| Category G | 0.0% | 0.0% | 0.0% | 0.0% | |
| Category H | 0.0% | 0.0% | 0.0% | 0.0% | |
| Category I | 0.0% | 0.0% | 0.0% | 0.0% |
Error rate = frequency/ # months; average monthly error rate = (# errors/ # opportunities to error)/ # months.
Not all medication errors were able to be appropriately typed due to varying amounts of error information collected in the first 27 months.
Information for Category A (safety concerns) and Category B (near-misses) were excluded due to lack of sufficient data.
MACC, medication administration cross-check; NCC MERP, National Coordinating Council for Medication Error Reporting and Prevention.
Medication errors by medication (entire study period, 54 months). Medications without errors are not listed.
| Medication | Error count | Doses | Overall relative error frequency |
|---|---|---|---|
| Adenosine | 1 | 396 | 0.25% |
| Albuterol | 1 | 7840 | 0.01% |
| Amiodarone | 1 | 253 | 0.40% |
| Aspirin | 1 | 8619 | 0.01% |
| Atropine | 12 | 2110 | 0.57% |
| Calcium chloride | 2 | 78 | 2.56% |
| Dextrose | 1 | 3714 | 0.03% |
| Epinephrine 1:1,000 | 2 | 179 | 1.12% |
| Epinephrine 1:10,000 | 2 | 7031 | 0.03% |
| Fentanyl | 27 | 7421 | 0.36% |
| Ketorolac | 2 | 63 | 3.17% |
| Labetalol | 0 | 34 | 0.00% |
| Lidocaine | 11 | 396 | 2.78% |
| Lidocaine drip 1G / 250D5W | 1 | 131 | 0.76% |
| Lorazepam | 11 | 796 | 1.38% |
| Magnesium sulfate | 3 | 109 | 2.75% |
| Midazolam | 9 | 685 | 1.31% |
| Narcan | 2 | 810 | 0.25% |
| NTG | 1 | 18,559 | 0.01% |
| Prednisone | 1 | 287 | 0.35% |
NTG = nitroglycerin.
Figure 3.Frequency of medication errors (measured on the primary axis) per month during the study period compared against the opportunities to error (doses administered); measured on the secondary axis.
Figure 4.Reduction in average monthly error rates.
*Indicates p < .025.